Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model

Published:2016-05 Issue:4 Volume:12 Page:933-943
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Jackman Joshua A.,Mészáros Tamás,Fülöp Tamás,Urbanics Rudolf,Szebeni Janos,Cho Nam-Joon

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference46 articles.

1. Nanomedicine;Kim;N Engl J Med,2010

2. The big picture on nanomedicine: the state of investigational and approved nanomedicine products;Etheridge;Nanomedicine,2013

3. Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties;Nijhara;Nanomedicine,2006

4. Nanomedicines: addressing the scientific and regulatory gap;Tinkle;Ann N Y Acad Sci,2014

5. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars;Mühlebach;Nanomedicine,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine;Molecular Therapy - Methods & Clinical Development;2024-09

2. Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies;Vaccine: X;2024-08

3. Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine;ACS Nano;2024-03-12

4. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma;Pharmaceutics;2024-02-23

5. Paclitaxel-lipid prodrug liposomes for improved drug delivery and breast carcinoma therapy;Chinese Chemical Letters;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3